Genetic counseling and testing for breast-ovarian cancer susceptibility: What do women want?

被引:54
作者
Audrain, J
Rimer, B
Cella, D
Garber, J
Peshkin, BN
Ellis, J
Schildkraut, J
Stefanek, M
Vogel, V
Lerman, C
机构
[1] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
[2] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[3] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Virginia Breast Canc Fdn, Richmond, VA USA
[6] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
关键词
D O I
10.1200/JCO.1998.16.1.133
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess preferences for the content and process of genetic counseling and testing for breast-ovarian cancer susceptibility among women at high risk for breast cancer. Methods: Ninety-eight healthy women who had a family history of breast cancer in at least two first-degree relatives participated in a structured telephone survey that evaluated preferences for type of provider and the content and process of pretest education and posttest genetic counseling. Results: Forty-two percent of women preferred that pretest education be delivered by a genetic counselor, while 22% preferred an oncologist. This preference was positively associated with a desire to discuss psychosocial issues during the session (P = .001), For posttest counseling, 38% of women preferred an oncologist, while 20% preferred a genetic counselor. However, women who desired supportive counseling during this session were significantly more likely to prefer a genetic counselor to an oncologist (P = .02). Fewer women wished to see a primary care physician or gynecologist for pretest education (11%) or posttest counseling (22%). With regard to the counseling process, 82% of women wished to self-refer for genetic counseling, but 63% desired advice and recommendations about whether to be tested. Conclusion: When feasible, the optimal approach may be for oncologists to work with genetic counselors to provide pretest education and medical recommendations, Elicitation of patients' preferences may be useful to determine the level of counseling services needed. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 29 条
[1]  
*AM SOC HUM GEN, 1994, AM J HUM GENET, V55, pR2
[2]   Interest in learning of personal genetic risk for cancer: A general population survey [J].
Andrykowski, MA ;
Munn, RK ;
Studts, JL .
PREVENTIVE MEDICINE, 1996, 25 (05) :527-536
[3]   A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing - Commentary [J].
Botkin, JR ;
Croyle, RT ;
Smith, KR ;
Baty, BJ ;
Lerman, C ;
Goldgar, DE ;
Ward, JM ;
Flick, BJ ;
Nash, JE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (13) :872-882
[4]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[5]   WOMENS RECEPTIVITY TO TESTING FOR A GENETIC SUSCEPTIBILITY TO BREAST-CANCER [J].
CHALIKI, H ;
LOADER, S ;
LEVENKRON, JC ;
LOGANYOUNG, W ;
HALL, WJ ;
ROWLEY, PT .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (08) :1133-1135
[6]  
CLAYTON EW, 1995, AM J HUM GENET, V57, P171
[7]   STATEMENT ON USE OF DNA TESTING FOR PRESYMPTOMATIC IDENTIFICATION OF CANCER RISK [J].
COLLINS, FS ;
BENJAMIN, LJ ;
BOTSTEIN, D ;
COX, JR ;
DAVIDSON, N ;
GRAY, JW ;
HOLTZMAN, N ;
HOUSMAN, DE ;
JAMISON, KR ;
NELKIN, D ;
ROTHSTEIN, R ;
SMITH, DC ;
SMITH, LM ;
SPENCE, MA ;
TILGHMAN, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (10) :785-785
[8]   4 MODELS OF THE PHYSICIAN-PATIENT RELATIONSHIP [J].
EMANUEL, EJ ;
EMANUEL, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2221-2226
[9]   The use and interpretation of commercial APC gene testing for familial adenomatous polyposis [J].
Giardiello, FM ;
Brensinger, JD ;
Petersen, GM ;
Luce, MC ;
Hylind, LM ;
Bacon, JA ;
Booker, SV ;
Parker, RD ;
Hamilton, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12) :823-827
[10]  
GRAHAM J, 1996, P AM SOC CLIN ONCOL, V15, P334